Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Single nucleotide Polymorphism
100%
Genetic Polymorphism
100%
Multiple Sclerosis
100%
High-dose Vitamin D
100%
Vitamin D Supplementation
100%
Vitamin D
100%
Genetic Risk
66%
25(OH)D Level
66%
Non-carriers
50%
High Risk
33%
Binding Protein
33%
Rs7041
33%
25(OH)D Status
33%
Risk Factors
16%
Metabolic Enzymes
16%
Placebo
16%
Multiple Sclerosis Treatment
16%
Relapsing-remitting multiple Sclerosis
16%
25-hydroxyvitamin D (25OHD)
16%
Vitamin D Metabolism
16%
Vitamin D3
16%
Clinical Consequences
16%
CYP27B1
16%
Inconclusive Result
16%
Rs4588
16%
CYP24A1
16%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Drug Megadose
100%
Multiple Sclerosis
100%
Genetic Polymorphism
100%
Allele
66%
Protein Binding
33%
Relapsing Remitting Multiple Sclerosis
16%
Biochemistry, Genetics and Molecular Biology
Genetic Polymorphism
100%
Drug Megadose
100%
Vitamin D
100%
Single-Nucleotide Polymorphism
60%
Allele
40%
Binding Protein
20%
Enzyme
10%
Genotyping
10%
Vitamin D Metabolism
10%
Cholecalciferol
10%
CYP24A1
10%
Neuroscience
Multiple Sclerosis
100%
Genetic Polymorphism
100%
Vitamin D
100%
Single-Nucleotide Polymorphism
54%
Protein Binding
18%
Placebo
9%
25 Hydroxyvitamin D
9%
Relapsing Remitting Multiple Sclerosis
9%
Cholecalciferol
9%
Enzyme Metabolism
9%
Colecalciferol 24 Hydroxylase
9%
Risk Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Vitamin D
100%
Binding Protein
18%
Placebo
9%
Cholecalciferol
9%
25 Hydroxyvitamin D
9%
Enzyme
9%